VVVV vVARDIS Holding AG

NYSE · US · Healthcare · Medical Instruments & Supplies · vvardis.com

16.50USDMkt Cap: —P/E: —1d ago

vVARDIS Holding AG, a dental medtech company, develops and provides non-invasive cavity treatment products in Switzerland and the United States. The company offers the Curodont platform, including Curodont Repair, a biomimetic system to arrest and reverse early caries through enamel regeneration; Curodont Protect, a remineralising tooth gel containing the biomimetic Oligo-Peptide 103 technology; and Enamel Serum, enriched with peptides and hydroxyapatite, which delivers calcium and phosphate ions to care for the enamel. The company was incorporated in 2020 and is based in Zug, Switzerland. vVARDIS Holding AG operates as a subsidiary of VVARDIS Investment Holding AG.…

Industry Peers

Medical Instruments & Supplies

Screen all Medical Instruments & Supplies

ISRG

Intuitive Surgical, Inc.

$153.77BUSDP/E 53.6

EssilorLuxottica Société anonyme

$92.38BUSDP/E 34.6

BDX

Becton, Dickinson and Company

West Pharmaceutical Services, Inc.

$29.01BUSDP/E 46.7

DIM

Sartorius Stedim Biotech S.A.

$24.00BUSDP/E 68.3

SRT3

Sartorius Aktiengesellschaft

Sartorius Aktiengesellschaft

Fisher & Paykel Healthcare Corporation Limited

$15.78BUSDP/E 61.4

FPH

Fisher & Paykel Healthcare Corporation Limited

$15.77BUSDP/E 56.4

SOLV

Solventum Corporation

$15.14BUSDP/E 100.1

BAX

Baxter International Inc.

$13.35BUSD

COO

The Cooper Companies, Inc.

$11.91BUSDP/E 21.5

ALGN

Align Technology, Inc.

$11.86BUSDP/E 24.5

Key Statistics

Company

Market Cap—

Enterprise Value730.44M USD

Revenue (TTM)—

Gross Profit—

Net Income (TTM)—

Revenue/Share—

Last Price16.50 USD

Fiscal Year End—

MR QuarterJun 2026

Employees138

CountryUS

SectorHealthcare

IndustryMedical Instruments & Supplies

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)—

PEG—

EV/EBITDA—

EV/Revenue—

P/S—

P/B-4.81

EPS (TTM)—

EPS (Forward)—

52W Range

—

52W High0.0000 USD

52W Low0.0000 USD

Profitability

Gross Margin0.00%

Oper. Margin0.00%

EBITDA Margin0.00%

Profit Margin0.00%

ROE—

ROA—

ROIC—

ROCE—

Growth

Revenue Growth214.20%

Earnings Growth—

Cash Flow & Leverage

Operating CF—

CapEx (TTM)—

FCF Margin—

FCF Yield—

Net Debt57.39M USD

Net Debt/EBITDA—

Net Debt/FCF—

Balance Sheet

Debt/Equity—

Current Ratio—

Quick Ratio—

Book Value/Sh-3.43 USD

Cash/Share0.85 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.00 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio—

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.—

Float—

Insiders—

Institutions—

Technical

SMA 50—

SMA 200—

Beta—

S&P 52W Chg12.75%

Avg Vol (30d)3.77M

Avg Vol (10d)—

Technical Indicators

RSI (14)—

MACD—

MACD Signal—

MACD Hist.—

BB Upper—

BB Middle—

BB Lower—

BB Width—

ATR (14)—

Vol Ratio (20d)—

About vVARDIS Holding (NYSE: VVVV)

›

vVARDIS Holding (NYSE: VVVV) is listed on the New York Stock Exchange, where its shares trade in USD. It belongs to the Medical Instruments & Supplies industry, part of the Healthcare sector, and reports about 138 employees.

The shares were at 16.50 USD on 13 November 2026.

vVARDIS Holding reports an operating margin of 0.0% and revenue up 214.2% year over year.

Its debt exceeds its cash by 57.39M USD.

Compare VVVV with ISRG and EL →